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Genetic inactivation of ClC-5, a voltage-gated chloride chan-
nel prominently expressed in the kidney, leads to proteinuria
because of defective apical endocytosis in proximal tubular
cells. Because thyroid hormone secretion depends on apical
endocytosis of thyroglobulin (Tg), we investigated whether
ClC-5 is expressed in the thyroidandaffects its function, using
Clcn5-deficient knockout (KO) mice. We found that ClC-5 is
highly expressed in wild-type mouse thyroid (40% of mRNA
kidney level). The protein was immunolocalized at the apical
pole of thyrocytes. InPercoll gradients,ClC-5 overlappedwith
plasma membrane and early endosome markers, but best co-
distributed with the late endosomal marker, Rab7. ClC-5 KO
mice were euthyroid (normal T4 and TSH serum levels) but
developed a goiter with parallel iodine and Tg accumulation
(i.e. normal Tg iodination level). When comparing ClC-5 KO
withwild-typemice, thyroid 125I uptake after 1 hwas doubled,
incorporation into Tgwas decreased by approximately 2-fold,
so that trichloroacetic acid-soluble 125I increased approxi-
mately 4-fold. Enhanced 125I efflux upon perchlorate and
presence of 125I-Tg as autoradiographic rings at follicle pe-
riphery demonstrated delayed iodide organification. Endo-
cytic trafficking of 125I-Tg toward lysosomes was not inhib-
ited. Expression of pendrin, an I/Cl exchanger involved in
apical iodide efflux, was selectively decreased by 60% in KO
miceatmRNAandprotein levels. Thus,ClC-5 iswell expressed
in the thyroid but is not critical for apical endocytosis, con-
trary to the kidney. Instead, the goiter associated with ClC-5
KO results from impaired rate of apical iodide efflux by down-
regulation of pendrin expression. (Endocrinology 147:
1287–1296, 2006)
THE ClC CHLORIDE channels are voltage-gated chan-nels involved in a broad range of physiological func-
tions in mammals. The family includes nine isoforms, which
operate at the plasma membrane or intracellular vesicles
(1–3). The functional inactivation of several of these isoforms
has been associated with diseases in man and mouse, point-
ing to a role in transepithelial transport, vesicular acidifica-
tion, and endocytic trafficking (1, 3). ClC-5 is mainly ex-
pressed in the kidney, where it has been located in different
tubular cell types, including the cells lining the proximal
tubules, proximal tubular cells (PTC). Although ClC-5 has
been localized in early endosomes in mouse kidney (4) and
PTC in culture (5), it occurs at the cell surfacewhen expressed
in Xenopus oocytes or HEK 293 cells, where it mediates
plasma membrane currents (6). ClC-5 elicits outward recti-
fying anion currents, with a selectivity for Br greater than
Cl and Cl greater than I (1). Inactivating mutations of
ClC-5 in patientswithDent’s disease (X-linked familial neph-
rolithiasis), cause low-molecular-weight proteinuria and cal-
ciuria, which are reproduced in ClC-5 knockout (KO) mice
(1, 5, 7–9). The tubular proteinuria caused by the loss of ClC-5
results from defective receptor-mediated apical endocytosis
of ultrafiltrated low-molecular weight proteins by kidney
proximal tubules (4, 7), which reflects a trafficking defect of
their multiligand receptors megalin and cubilin (10). It is
currently proposed that ClC-5 may have a role in proper
endosomal acidification, which is necessary to support nor-
mal vesicular trafficking, by providing the anion conduc-
tance linked to the electrogenic vacuolar H-ATPase (1, 3,
11). Two independent studies (12, 13) have recently shown
that the mammalian ClC-5 can also function as chloride/
proton exchanger, similar to the Escherichia coli ClC-ec1 iso-
form (14), when activated by positive voltages. It may thus
be regarded as an antiporter that could control endosomal
acidification by coupling Cl gradients to vesicular pH
gradients.
A key step in thyroid hormone secretion is the apical
endocytosis of the prohormone thyroglobulin (Tg). This is
followed by their proteolytic release as a result of cathepsins
in the late endocytic apparatus (15) and their secretion across
the basolateral membrane. Moreover, the rate of thyroid
hormone production correlates with the expression of en-
docytic catalysts promoting Tg uptake (Rab5) and transfer to
late endosomes-lysosomes (Rab7), respectively (16). Being
present at a huge concentration in the follicular lumen, Tg is
predominantly internalized by fluid-phase endocytosis and
addressed to lysosomes. In addition, selective receptor-me-
diated endocytosis has been reported at lowTg concentration
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in vitro (17, 18), but the identity of the receptor(s) involved
remains elusive. The multiligand receptor megalin, which
can interactwith Tg, occurs at the apical surface of thyrocytes
(19, 20), but its role in thyroid hormone secretion remains
controversial. In most absorptive epithelial cells, including
kidney PTC,megalinmediates transfer to lysosomes for deg-
radation. In polarized rat FRTL-5 cells, megalin promotes Tg
endocytosis, but the prohormone internalized by this mech-
anismwas reported to bypass lysosomal degradation and be
released in the basolateral medium by transcytosis (19, 21).
Active I uptake by thyrocytes, transfer to the follicular
lumen, and incorporation into Tg are key steps in thyroid
hormone synthesis. In polarized thyrocyte monolayers,
transepithelial traffic of I is from basolateral to apical (22).
Iodide is actively transported at the basolateralmembrane by
the Na/I symporter, NIS/SLC5A5 (23), and rapidly trans-
ferred to the follicular lumen by apical iodide channel(s)
acutely regulated by TSH (21). The I/Cl apical exchanger
pendrin (PDS/SLC26A4) is defective in Pendred’s syndrome
(24, 25) and is regarded as a key, but not exclusive, mediator
of apical iodide efflux (25–28).
The presence of Cl in the thyroid follicular lumen is
necessary to support I efflux by the pendrin exchanger (29).
Cl is vectorially transported through the basolateral
(NaK2Cl) symporter and apical anion channel(s), the
molecular identity of which remains unknown (30). Electro-
physiological studies have identified in the apical membrane
of thyrocytes low-conductance Cl currents regulated by
cAMP (31, 32). The cystic fibrosis transmembrane conduc-
tance regulator (CFTR) controlled by phosphorylation via
cAMP-dependent and other kinases, is the only apical Cl
channel demonstrated in the thyroid gland at mRNA and
protein levels (33). Although the thyroid function is pre-
served in patients with cystic fibrosis under appropriate io-
dine supply, they are more susceptible to hypothyroidism
upon iodide excess, suggesting that CFTR could participate
in apical iodide efflux (34). No member of the ClC chloride
channel family has so far been reported in the thyroid gland.
The present study aimed at investigating the expression of
ClC-5 in the thyroid gland and its possible role in apical Tg
endocytosis. We first showed that ClC-5 is abundantly ex-
pressed in the mouse thyroid. Second, to explore its function
therein, we took advantage of ClC-5 KOmice. Our data show
that ClC-5 is not critical for Tg endocytosis in the thyroid.
Instead, ClC-5 inactivation leads to a euthyroid goiter with




Two groups, each of 30 wild-type (WT) C57BL/6J male mice, 6 wk
of age, were used for studies of ClC-5 expression and distribution in the
thyroid. Three groups (A, B, and C) of ClC-5 KO male mice (Clcn5/Y),
created by deletion of exon VI of Clcn5 (7), were compared with WT
(Clcn5/Y) age-matched adult male mice. The effect of agingwas further
analyzed by comparing adultmice at 5 and 12months of age (experiment
B, in which a perchlorate discharge test was performed at 12 months).
The thyroid of a male Wistar rat was used for deglycosylation experi-
ments. Investigations were carried out in accordance with National
Institutes of Health regulations for the care and use of laboratory
animals.
RNA extraction and mRNA measurement
Total RNAwas isolated frompooled thyroids of 30WTmice and from
one kidney with the RiboPure kit followed by DNase I digestion (Am-
bion, Austin, TX). Total RNA was reverse transcribed into cDNA using
ThermoScript RT-PCR System with total RNA primed with oligo(dT)
(Invitrogen, Merelbeke, Belgium). RT-PCR were performed with 500
nmol/liter of both sense and antisense primers (Eurogentec, Seraing,
Belgium; see sequence in Table 1) in a final volume of 20 l (MyiQ;
Bio-Rad, Hercules, CA). Size and purity of produced amplicons were
analyzed by gel electrophoresis. Real-time PCR conditions were per-
formed with denaturation at 95 C for 10 min, followed by 45 cycles of
20 sec at 95 C, 30 sec at 60 C, and 10 sec at 50 C. The melting temperature
of PCR products was checked at the end of each PCR by recording SYBR
green fluorescence decrease upon slowlydenaturatingDNA. Expression
of ClC-5 in normal mouse thyroid was compared with that in kidney by
semiquantitative RT-PCR and by real-time PCR, as reported (35). For
relative mRNA quantification in WT and ClC-5 KOmice, real-time PCR
analyses were performed in duplicate on total RNA extracted from
single thyroid lobes of five differentmice or on 400 ng total RNA of three
kidneys. To normalize for differences in the amount of total RNA added
to the reaction, mRNA levels of the target genes were adjusted to glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels deter-
mined simultaneously, after confirmation that this internal control was
not affected by ClC-5 deletion. The reaction conditions were optimized
to ensure that PCRefficiencies of the target genes andGAPDHgenewere
comparable, using standard curves of serial dilutions of normal mouse
thyroid and kidney cDNA. Because mRNA levels of pendrin, megalin,
Rab5a, and Rab7 in the kidney were not influenced by the loss of ClC-5,
relative changes in mRNA level in thyroids of WT and KO mice were
determined by comparison with kidney mRNA level using the 2Ct
method (35, 36). Results were expressed as normalized thyroid values
relative to the kidney chosen as the calibrator.
TABLE 1. Primer sequences
Gene Sequences (5–3) Amplicon size (bp)
CIC-5 Sense AAGTGGACCCTTGTCATCAA 135
Antisense ACAAGATGTTCCCACAG (exon IV)
Pendrin Sense GGAAAAGTCTACGCCACCAA (1317–1337) 72
Antisense GCTTATCCCAAAGGCAATGA (1369–1389)
Megalin Sense CACAGGTGACTGTACCAGAA (13762–13781) 380
Antisense GTCAGTGTCTAAATGTTCCC (14141–14122)
Rab5a Sense GACTTAGCAAATAAAAGAGC (874–894) 75
Antisense TCACTAAGGTCTACTCCTCG (1057–1077)
Rab7 Sense TCAATATGCGTCCCTCCTC (833–851) 73
Antisense TGGAGTTTCTTTTGGCAGC (887–905)
GAPDH Sense TGCACCACCAACTGCTTAGC 176
Antisense GGATGCAGGGATGATGTTCT (exon I)
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Analytical subcellular fractionation
Thyroid glands from 30WTmice or from four pairs of WT and ClC-5
KO mice injected with 125I at 1 h before euthanasia were pooled and
homogenized in 250 mm sucrose, 10 mm Tris, pH 7.4. One kidney
homogenate was prepared similarly for comparison. Thyroid homog-
enates were centrifuged at 134,000 g for 45 min to isolate a high-speed
pellet and a supernatant, in both of which total and trichloroacetic acid
(TCA)-soluble radioactivitywasmeasuredwhen appropriate. The pellet
was suspended in the initial volume of buffer, loaded onto 20% (vol/vol)
Percoll (Amersham Pharmacia, Roosendaal, The Netherlands) in su-
crose-Tris buffer and further resolved by centrifugation at 53,000 g for
30min (16, 37). Eleven fractions, collected from the bottom,were assayed
for density and cathepsin D activity, and aliquots of equal volume were
analyzed by Western blotting. Radioactivity was measured to compare
125I trafficking in WT and KO mice.
Western blotting
Homogenates, high-speed pellets, and fractions of the Percoll gradi-
ent were resolved by SDS-PAGE and transferred onto polyvinylidene
fluoride membrane as previously described (16). After blocking, mem-
branes were incubated overnight at 4 C with the following primary
rabbit antibodies: ClC5 (7) (SB499; 1:1000), megalin (a kind gift of Dr. P. J.
Verroust, Hopital St. Antoine, Paris, France; 1:10,000), Rab5a (Santa Cruz
Biotechnology, Santa Cruz, CA; 1:500), Rab7 (a kind gift of Dr. M. Zerial,
Max-Planck Institute, Dresden, Germany; 1:2000), and the iodide sym-
porter NIS (a kind gift from Dr. P. Kopp, Northwestern University,
Chicago, IL; 1:1000); with chicken antimouse pendrin (also from Dr. P.
Kopp; 1:1000); or mouse monoclonal antibody against the 31-kDa E1
subunit of the vacuolar H-ATPase (a kind gift of Dr. S. Gluck, Wash-
ington University, St Louis, MO; 1:1000) and the 1-subunit of Na/
K-ATPase (Upstate Biotechnology, Lake Placid, NY; 1:2000). Western
blots were revealed by appropriate secondary antibodies for rabbit (Bio-
Source, Camarillo, CA), chicken (Promega, Leiden, The Netherlands) or
mouse IgG (Biosource), followed by enhanced chemiluminescence (Per-
kin-Elmer, Zaventem, Belgium) and quantification by using Scion (Fred-
erick, MD) IMAGE 4.0.2 (10).
Light microscopy
A thyroid lobe was dissected from several WT and KO mice, imme-
diately fixed by 4% formaldehyde in PBS (pH 7.4) for 2 h, embedded in
paraffin, and stained with hematoxylin-eosin. For ClC-5 immunoper-
oxidase, 6-m sections were first incubated for 30 min with 0.3% H2O2
to inactivate the endogenous thyroperoxidase. Antigen retrieval and
immunolabeling were performed as described (35). For autoradiogra-
phy, 4-m sections were covered with Ilford L4 emulsion (Kodak,
Zaventem, Belgium) and exposed for 3 wk, as previously reported (38).
125I uptake
Mice were injected with 15 Ci 125I (IMS 30; Amersham Bioscience),
either ip (experiment B) or iv (experiment C) at 1 h before euthanasia.
After exsanguination, thyroid glands were carefully dissected out and
125I uptake was individually measured. For the perchlorate discharge
test, 100 l of 10 mm NaClO4 were injected ip at 1 h after
125I pulse to
two pairs of 12-month-old WT and ClC-5 KO mice that were killed 1 h
later. Radioactivity remaining in thyroid glands was compared with the
125I uptake measured in glands from two other pairs of mice of the same
age without the iodide chase. Protein-bound serum 125I (PB125I) was
determined after TCA precipitation.
Analytical procedures
Protein and [127I]iodine concentration were measured in individual
homogenates and fractions as reported (16). Tg concentration in the
homogenates was calculated from the proportion of 19S and 27S Tg in
the high-speed supernatant, after centrifugation on 5–20% sucrose gra-
dients and analysis at 210 nm of the distribution profile, as reported (16,
37). Cathepsin D activity was determined as described (37). T4 concen-
tration was measured by RIA using a commercially available kit for
mouse serum (Beckman Coulter Co., Marseille, France). Serum TSHwas
determined by RIA using a kit for rat TSH (Amersham Bioscience).
Statistical analyses
Biochemical values for WTmice are presented as means sd; for KO
mice, single results were considered significant when out of confidence
limits at 95% for WT means.
Results
ClC-5 is well expressed in mouse thyroid gland and is
located at the apical pole of thyrocytes
Previous studies have disclosed that ClC-5 is predomi-
nantly expressed in the kidney, with much lower mRNA
contents in brain, liver, lungs, and testes; the thyroid gland
was not examined (1, 5, 7).We foundby semiquantitative and
quantitative real-time PCR that ClC-5 mRNA is significantly
expressed in mouse thyroid gland, reaching approximately
40% of kidney level (Fig. 1A). By Western blotting, ClC-5
protein level in the thyroid gland was approximately 15% of
kidney (Fig. 1B). The electrophoretic pattern differed be-
tween the two organs; in the thyroid gland, the major species
was a broad band atMr approximately 90, with an additional
weak band at Mr approximately 80 (lanes 1 and 2). The latter
isoform was predominantly expressed in the kidney (lanes 5
and 6). Both immunoreactive bands in the thyroid gland
were abolished when using antibodies preadsorbed on the
immunogenic peptide (lane 3) and were absent from ClC-5
KO thyroid glands (lane 4). Because ClC-5 is a glycoprotein,
we addressed the difference in electrophoretic mobility be-
tween the thyroid and the kidney by a comparative degly-
cosylation study (35). Treatment with N-glycosidase F
shifted the ClC-5 bands of both organs to the same single
narrow band of indistinguishable mobility (Mr approxi-
mately 70), indicating that ClC-5 bears more glycan chains in
the thyroid than in the kidney (data not shown).
ClC-5 was next localized in mouse thyroid gland by im-
munohistochemistry. A strong staining was observed at the
apical pole of normal thyrocytes (Fig. 1C, left). The pattern of
staining was heterogeneous between follicles and between
groups of cells in the same follicle. No staining was found
when sectionswere incubatedwith preimmune antiserum or
with the immune serum preadsorbed on the immunogenic
peptide (data not shown). There was no staining in ClC-5 KO
thyroid gland (Fig. 1C, right).
ClC-5 KO mice develop a euthyroid goiter
All 5-month-old ClC-5 KO mice that were examined de-
veloped a goiter (Fig. 2, A and B). By histology, this goiter
showed follicles of normal size surrounded by mostly cubic
thyrocytes, as in WT thyroid glands, filled with a colloid
evenly stained with hematoxylin-eosin (Fig. 2, C and D).
Composition was analyzed in three thyroid homogenates of
WT and KO mice (experiments A–C). Because WT values
showed little variation, they were pooled as a common ref-
erence group, towhich individual KOvalueswere compared
(Table 2).
Thyroid enlargement in individual groups of KO mice, as
measured by total protein content, varied from 1.7- to 5-fold.
Goiter developmentwas paralleled by a comparable increase
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in soluble Tg. Sedimentation of soluble proteins on sucrose
gradients revealed that a higher proportion of Tg occurred
as 27S dimers in KO compared with WTmice (15 4 vs. 8
2% of total Tg; n  3; P 	 0.05). Cellular protein, estimated
as total protein minus Tg, also increased although less than
Tg. Soluble thyroid iodine,which represented approximately
80–90% of total iodine in all groups of mice, showed higher
increase than total and cellular proteins, from2- to 8-fold. The
ratio of total iodine to Tg, a bona fide reflection of Tg iodi-
nation level, was not different between WT and KO glands.
Goiter and its biochemical parameters further increasedwith
age in KO mice (Table 2, compare 5 vs. 12 months).
ClC-5 codistributes with endosomal and plasma
membrane markers
In kidney, ClC-5 colocalizes by immunofluorescence with
the vacuolar H-ATPase in subapical endosomes (11) and
codistributes by analytical subcellular fractionationwith vac-
uolarH-ATPase (39) and the endosomalmarkers Rab5a and
Rab7 (Auzanneau, C., R. Fuchs, G. Dom, S. E. Guggino, W.
B. Guggino, O. Devuyst, and P. J. Courtoy, in preparation).
We analyzed the thyroid subcellular distribution of ClC-5 in
comparison with basolateral plasma membrane (NIS and
Na/K-ATPase), apical plasma membrane (pendrin and
megalin), and endosomal (vacuolar-ATPase and Rab5a for
early endosomes; Rab7 for late endosomes) and lysosomal
markers (cathepsin D activity). ClC-5-bearing particles dis-
tributed as a symmetrical peak in the light-density part of the
FIG. 1. The chloride channel, ClC-5, is well expressed inmice thyroid
gland. A, RT-PCR. Expression of ClC-5 and GAPDH mRNA was
compared in the thyroid gland and kidney by semiquantitative RT-
PCR (left). ClC-5 mRNA was further measured by quantitative real-
time PCR in duplicate, normalized to GAPDHmRNA, and expressed
by reference to the kidney (100%; right). B, Western blotting. The
protein amounts indicated below each lane for thyroid cells (i.e. to-
tal Tg; lanes 1–4) and total kidney (lanes 5 and 6) were resolved by
7.5% SDS-PAGE and probed with the anti-ClC-5 rabbit antibodies. In
the thyroid gland (lanes 1 and 2), ClC-5 mostly migrates as a broad
band aroundMr 90 (arrowhead at left), and shows aminor band at Mr
approximately 80 (arrow), its position in the kidney (lanes 5 and 6).
Specific controls included antibody adsorption on immunogenic pep-
tide (lane 3) and analysis of ClC-5 KO extracts (lane 4). C, Immuno-
peroxidase. In WT thyroid gland at left, ClC-5 is restricted to the
apical cytoplasm of thyrocytes, with heterogeneous expression be-
tween cells. KO mice show no ClC-5 staining (right).
FIG. 2. Anatomy and functional histology: ClC-5 KO mice develop a
goiter. A and B, Overview of the thyroid gland from 5-month-old WT
and KOmice. Induction of goiter in the ClC-5 KOmice is obvious (see
also Table 2). C and D, Conventional histology. There is no difference
in mean follicle size between WT and KO mice, and colloid is homog-
enously stained by hematoxylin-eosin. E and F, Autoradiography at
1 h after 125I injection (part of experiment C, Table 2). In WT thyroid
gland, most follicles show diffuse homogenous autoradiographic la-
beling of the colloid. In KOmice, labeling is predominantly restricted
to a peripheral ring, indicating delayed mixing of [125I]Tg with the
colloid.
1290 Endocrinology, March 2006, 147(3):1287–1296 van den Hove et al. • Absence of ClC-5 Delays I Efflux in the Thyroid
Percoll gradient (Fig. 3B). ClC-5 was not resolved from the
basolateral membrane marker Na/K-ATPase and the so-
dium/iodide symporter NIS (Fig. 3A). ClC-5 also largely
overlapped with megalin (Fig. 3C). However, particles de-
rived from the apical plasmamembrane and bearing pendrin
penetrated much more slowly in the gradient and were re-
markably resolved from the distribution ofmegalin (Fig. 3C),
indicating either that megalin in the thyroid gland is not
abundant at the apical membrane but mostly occurs in en-
dosomes (in the kidney proximal tubules, megalin occurs at
both apical plasma membrane and endosomes) or that dif-
ferent apical domains were resolved. A denser shoulder of
megalin distribution could indeed correspond to microvilli,
as in kidney (10). ClC-5 also overlapped with vacuolar AT-
Pase and with the early endosomal marker Rab5a (Fig. 3E)
and showed almost perfect codistribution with the late en-
dosomal marker Rab7 (Fig. 3B). Finally, ClC-5 was fully
resolved from lysosomes, the dense component of cathepsin
D distribution (Fig. 3D). The cathepsin D activity that re-
mained at the top of the gradient most likely reflects soluble
enzymes released during homogenization.
ClC-5 KO mice show delayed iodide organification
The dynamics of iodide processing was further analyzed
by following the fate of radioiodide at 1 h after injection,
either ip or iv (Table 3). Iodide accumulation in the thyroid
glandwas 2- to 3-fold higher inClC-5KO than inWTmice. The
thyroid content of 125I remaining soluble inTCA increased even
more (4- to8-fold),whereas the fractionof total 125I incorporated
TABLE 2. Composition of thyroid glands in paired CIC-5 WT and KO mice
WT KO
Experiments A–C Experiment B Experiment A Experiment B Experiment C Experiment B
Age (months) 5 12 5 5 5 12
Thyroid protein (g/gland)
Total 332  26 711 509 719 1840 5304
Tg 177  23 323 370 446 1086 3229
Cellular (total  Tg) 155  21 388 139 273 754 2075
Soluble 127I (g/gland) 1.4  0.2 3.8 3.7 4.9 9.7 26
Tg iodination level (g iodine/100 g Tg) 0.8  0.2 1.2 1.0 1.1 0.9 0.8
Homogenates of four thyroids were prepared from three groups (A, B, and C) of 5-month-old, or one group of 12-month-old (B) CIC-5 WT
and KOmice. Results for WTmice were pooled and are means SD (n 3). Results for KOmice were individual values considering the marked
variability between groups. All values in CIC-5 KO mice are statistically different from WT (P 	 0.05), except for Tg iodination level.
FIG. 3. Subcellular fractionation: ClC-5 is resolved from
pendrin and lysosomes and is not critical for Tg endo-
cytosis and transport to lysosomes. A–E, Thyroid glands
from 30 WT mice were pooled and homogenized, and a
postnuclear supernatant was loaded on 20%Percoll (vol/
vol, final). After centrifugation, 10 fractions were col-
lected, analyzed for density (dotted line in B), cathepsin
D activity (E), and Western blotting for the indicated
constituents. The distribution of ClC-5 is superimposed
in broken lines to other markers for comparison. F, Par-
ticulate pellets were isolated from homogenates of four
thyroid glands obtained at 1 h after 125I injection to
5-month-old WT and ClC-5 KOmice (experiment B) and
run in parallel Percoll gradients to determine 125I pro-
gression toward lysosomes. Radioactivity was TCA in-
soluble all over the gradient.Distributions are presented
as percentage of the maximal value.
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into Tg was decreased in KO mice, pointing to a partial or-
ganification defect. This hypothesis was tested by a perchlorate
discharge test performed in 12-month-old mice. In WT mice,
82% of the 125I taken up in the thyroid at 1 h (0.33% of injected
dose) remained in the gland after an additional 1 h of perchlor-
ate chase, indicating that 125Iwas rapidlyorganified. In contrast,
the perchloratedischarge testwaspositive inKOmice; about 50%
(55 and 38%) of 125I taken up after 1 h (0.72% of injected dose)
was free to exit from the gland upon the perchlorate chase,
which strongly suggests a partial organification defect.
To characterize the process of organification at the tissue
level, sections were analyzed by autoradiography at 1 h after
125I injection. InWT thyroid glands, 125I incorporation into Tg
led to an even autoradiographic labeling of the colloid in
most follicles, indicating no rate-limiting diffusion of radio-
iodine in the lumen and/or rapid mixing of newly iodinated
Tg within the colloid (Fig. 2E). In contrast, in ClC-5 KO
glands, the signal was weaker, pointing to poor retention of
injected 125I (because of defective incorporation in Tg). In
addition, most follicles showed preferential retention of au-
toradiographic grains as peripheral rings, indicating a low
mixing of newly labeled [125I]Tgwith preexisting colloid (Fig.
2F). Taken together, these results suggested that ClC-5 de-
letion delayed iodide delivery to the extracellular site of
organification.
Tg trafficking and thyroid hormone secretion are not
impaired in ClC-5 KO mice
In kidneys, the loss of ClC-5 impairs receptor-mediated
endocytosis by defective trafficking of megalin and cubilin
(10). To asses whether similar changes occur in the thyroid,
WT and ClC-5 KO mice were killed at 1 h after 125I injection,
thyroid glands were homogenized, and high-speed pellets
were resolved by Percoll density gradients as above (Fig. 3F).
In WT mice, one third of the 125I remained at low density,
compatible with association with plasma membrane parti-
cles marked by pendrin; half of the radioactivity was trans-
ferred to the endosomal region of the gradient (fractions
3–6), and only approximately 15% sedimented with lyso-
somes in the dense part of the gradient. In contrast, in KO
mice, the proportion of 125I reaching the density of the ly-
sosomal marker, cathepsin D, was doubled (30%). These
results indicate that, contrary to the kidney, endocytosis and
transfer to lysosomes of newly iodinated [125I]Tg was not
delayed but rather accelerated in ClC-5 KO mice.
Circulating levels of T4 and TSH and of PB
125I, an estimate
of [125I]hormone secretion, were nearly identical in WT and
ClC-5 KO mice (Table 3), indicating that KO mice are eu-
thyroid. Altogether, these results show that ClC-5 absence in
the thyroid gland does not slow down Tg endocytosis and
proteolytic release of thyroid hormones and suggest that
comparable PB125I levels in KO and in WT mice reflect the
combination of accelerated endocytosis of newly iodinated
Tg with fewer [125I]iodothyronine residues per Tg molecule.
Pendrin expression is selectively decreased in ClC-5
KO mice
The association of a euthyroid goiter with delayed iodide
organification and positive perchlorate discharge test, as re-
ported here, is highly reminiscent of patients with Pendred’s
syndrome (28). Therefore, we looked for the effect of ClC-5
deletion on pendrin expression by real-time PCR and West-
ern blotting (Fig. 4). In ClC-5 KO mice, pendrin mRNA and
protein levels were decreased by more than 60% in the thy-
roid glands compared with WT mice, with no difference in
corresponding kidneys, indicating that the deficit of expres-
sion is specific for the thyroid gland. The decrease in pendrin
mRNA expression in ClC-5 KO thyroid contrasted with nor-
mal thyroid and kidney mRNA levels for the apical mem-
brane receptor megalin and for the two endocytic catalysts
Rab5a and Rab7. Interestingly, comparison of mRNA levels
between both organs of WT mice showed that pendrin ex-
pression in the thyroid reached only approximately 2% of the
kidney level. Thyroid expression of megalin was also much
lower (5%) than in kidneys, but Rab5a and Rab7 mRNA
levels were higher in the thyroid than in kidneys (780 and
150%, respectively). ByWestern blotting,megalin abundance
was preserved or increased in the thyroid gland of ClC-5 KO
mice, whereas that of the endocytic catalysts Rab5a and Rab7
was not altered (Fig. 4). The expression of the basolateral
iodide symporter NIS (data not shown), which is not ex-




B 0.27  0.13 (6) 0.75  0.17a (5) 2.7
C 0.62  0.13 (4) 1.13  0.28a (4) 1.8
125I in Tg (% of uptake)
B–C 72–57 56–20 0.78–0.35
TCA-soluble [125I]iodide (% of uptake)
B–C 7–35 22–73 3.1–2.1
Serum
PB125I (%/ml)
B 9.5  2.7 (5) 6.7  1.4 (4) 0.7
C 13.8  1.9 (4) 11.4  2.2 (4) 0.8
T4 (nM) 28.1  4.6 (10) 29.5  8.6 (8) 1.0
TSH (ng/ml) 3.3  1.6 (5) 3.3  0.9 (7) 1.0
125I was injected ip in mice of group B and iv in mice of group C (15 Ci/mouse). Pulse-labeling was for 1 h. Values are means  SD (number
of mice). Distribution of 125I in Tg and of [125I]iodide soluble in TCA was measured in thyroid homogenates (see Table 2).
a P 	 0.05.
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pressed in the kidney, was increased in the same proportion
as the 125I uptake.
Discussion
This study shows that the chloride channel ClC-5 is abun-
dantly expressed in mouse thyrocytes and that deletion of
ClC-5 in mouse leads to a euthyroid goiter. The goiter is not
caused primarily by Tg accumulation resulting from a deficit
of endocytic uptake but results from the compensation by
hyperplasia of delayed iodide organification, which corre-
lates with a strong reduction of pendrin expression. Thus,
absence of ClC-5 in mice thyroid gland mimics the thyroidal
phenotype of patients with Pendred’s syndrome. These data
offer new perspectives into the molecular mechanism of Tg
endocytosis and on the role of ClC-5 in the thyroid.
The loss of ClC-5 does not impair endocytic uptake of Tg
and transfer to lysosomes: implications for the mechanisms
of Tg endocytosis and trafficking
The molecular mechanisms of apical Tg uptake, in par-
ticular the significance of a possible receptor-mediated en-
docytosis at the huge Tg luminal concentration (10 g/100
ml), and the role of receptor(s) in intracellular trafficking to
late endosomes/lysosomes where Tg proteolysis releases
thyroid hormones are still debated. Tg is a ligand of megalin,
a high-capacity receptor expressed at the apicalmembrane of
thyrocytes (20). Competition by the receptor-associated pro-
tein has been presented as functional evidence for a role of
megalin in receptor-mediated endocytosis of Tg by rat
FRTL-5 cells in vitro (19, 21). Furthermore, intriguing obser-
vations were reported to suggest that megalin shows pref-
erence for Tg bearing low hormonogenic content and directs
its intracellular trafficking to avoid lysosomes and to be
released instead intact by transcytosis at the basolateral
membrane. In contrast, hormone-rich Tg would be taken up
by fluid-phase endocytosis and be transported to lysosomes
for effective hormone release (20). However, no clear evi-
dence has yet been provided for competition by receptor-
associated protein in the uptake by thyrocytes of Tg at the
huge concentration prevailing in the follicular lumen.
In kidney PTC, the loss of ClC-5 is associated with a major
decrease (by 7-fold) in receptor-mediated endocytosis of
low-molecular-weight proteins. This endocytic defect is
caused by a megalin trafficking defect, causing disappear-
ance of the receptor from the apical plasmamembranewhere
the protein cargo is taken up, associated with an additional
impairment in cargo transfer to lysosomes (10). By contrast,
we found no evidence for a deficit of megalin-mediated Tg
endocytosis in the thyroid of ClC-5 KO mice. Indeed, the
endocytic processing of hormone-rich [127I]Tg generated nor-
mal circulating T4 levels. Moreover, uptake and transfer to
lysosomes of pulse-labeled Tg at 1 h after 125I injection were
accelerated. Preferential endocytosis of [125I]Tg, present as
autoradiographic rings at the periphery of the follicular lu-
men, is in agreement with the last-come, first-served model
of Tg handling (40).
The contrast between accelerated transfer of [125I]Tg to
lysosomes and normal release of 125I-labeled thyroid hor-
mones (measured as [125I]PBI) could be explained by delayed
intramolecular coupling of [125I]iodotyrosyl side chains to
generate [125I]thyronines in Tg (a mechanism highly depen-
dent on the availability of iodine). An alternative explanation
would be impairment of [125I]Tg proteolysis to release thy-
roid hormones in the late endocytic structures with which
ClC-5 preferentially associates in the thyroid gland, for ex-
ample by defective acidification (41). However, accelerated
transfer of [125I]Tg to lysosomes and normal circulating T4
levels in ClC-5 KO mice argue against a necessary role of
ClC-5 in the acidification of the endosomal/lysosomal com-
partment where thyroid hormones are released from Tg.
FIG. 4. Pendrin expression is selectively decreased in ClC-5KOmice.
Left, Real-time PCR. Expression in thyroid gland relative to kidney
of pendrin,megalin, Rab5a, andRab7 is compared in ClC-5WT (white
bars) and KO mice (gray bars). RNA was extracted individually from
three kidney homogenates and five thyroid lobes. Because total RNA
could not be measured in thyroid extracts, each mRNA level was
adjusted to that of GAPDH. Data in thyroid, normalized to this en-
dogenous reference, were then expressed relative to the same nor-
malized value in kidney, taken as the unit. Kidney was arbitrarily
chosen as the calibrator because no difference in pendrin, megalin,
Rab5a, and Rab7 expression was found between kidneys of WT and
ClC-5 KOmice. Results aremeans SD. The asymmetric distribution
of values is a consequence of converting the results of an exponential
process (Ct is exponentially related to copy number) into a linear
comparison of amounts (36). The only significant difference in ClC-5
KO mice is an approximately 4-fold decreased expression of pendrin
mRNA in the thyroid (P	 0.05). InWTmice, mRNA expression in the
thyroid gland compared with the kidney is much lower for pendrin
(1.8%) andmegalin (5%), higher for Rab7 (150%), andmuch higher for
Rab5a (780%). Right, Representative immunoblots of thyroid high-
speed pellets from WT and ClC-5 KO mice (10 g protein per lane).
Position of molecular mass markers is indicated at right. By densi-
tometry, pendrin level in thyroid glands of KO mice was 40% of the
WT level, megalin abundance was increased, and Rab5a and Rab7
were unchanged.
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Fluid-phase endocytosis is an alternative mechanism for
uptake of Tg. In contrast to receptor-mediated endocytosis,
fluid-phase endocytosis is not impaired in kidney PTC of
ClC-5KOmice (10). Thus, if Tg is essentially internalized into
thyrocytes by this bulky mechanism as a consequence of its
huge concentration found in the follicular lumen, a normal
rate of Tg endocytosis in the thyroid gland of ClC-5 KOmice
is to be expected. In fact, global release of thyroid hormones
from Tg was preserved in ClC-5 KO mice, as shown by their
euthyroid status, and thyroid expression of the rate-limiting
endocytic catalysts Rab5a and Rab7 (16) was not changed, as
in kidney (10). Moreover, we did not observe in the glands
such large follicles surrounded by flat epithelial cells as oc-
curring in aging mice when the rate of endocytosis is slowed
down (42).
The loss of ClC-5 is associated with a delay in iodide
organification: implications for apical iodide transport
Despite avid iodide thyroid uptake and parallel increase
of the iodide symporter NIS abundance, the efficiency of 125I
incorporation into Tg was strongly decreased in ClC-5 KO
mice, and diffusion of [125I]Tg in the colloid was far from
being completed at 1 h after pulse. However, the normal 127I
iodination level of Tg indicates that the thyroperoxidase ma-
chinery for oxidation was qualitatively preserved. The ac-
cumulation of 125I in a perchlorate-sensitive pool is thus
consistent with a defect in its rate of apical efflux. The oc-
currence of a selective I channel, impermeable to chloride
and distinct from the CFTR, has been demonstrated by func-
tional reconstitution into liposomes (43). However, the iden-
tity of this apical iodide channel is still unknown. A protein
homologous to NIS but located at the apical membrane of
thyrocytes (SLC5A8) was initially proposed as a putative
apical iodide transporter (44) but has since been identified as
a transporter of short-chain fatty acids (45).
Recent functional studies in polarized MDCK cells ex-
pressing NIS have demonstrated that coexpression with WT
pendrin, an I/Cl exchanger, is sufficient to mediate apical
iodide transport. In contrast, coexpression of NIS with two
PDS mutants, identified in a euthyroid patient having Pen-
dred’s syndrome, completely failed to promote iodide efflux,
despite the only partial organification defect observed in this
patient (27). This indicates that iodide may reach the follic-
ular lumen independently of pendrin, as also indirectly sup-
ported by the clinically and biochemical euthyroid status of
most individuals with Pendred’s syndrome, at least under
adequate nutritional iodide supply (24, 28), and by absence
of a thyroidal phenotype in pendrin KO mice (46). The in-
trinsic partial transport deficit is thus fully compensated by
an increased number of less active cells, which explains the
euthyroid goiter of Pendred’s patients. Different factors may
account for the phenotypic variability of this adaptation
mechanism inClC-5KOmice. First, nutritional iodide intake,
known to be lower in Europe than in the United States, may
become inadequate, leading to transient iodine deficiency
with increased serum TSH level, especially at a crucial stage
of development. Second, iodine turnover is much faster in
mouse than in human. Indeed, daily thyroid T4 secretion
requires endocytosis of more than 25% of the iodine pool
stored in Tg in the mouse but only 1% in the human. This
might explain why Dent’s patients do not apparently de-
velop a goiter (Devuyst, O., and R. V. Thakker, unpublished
data).
We therefore suggest that ClC-5 could act as an alternative
FIG. 5. Three models of ClC-5 channel function and interaction with pendrin (PDS) in normal thyrocytes. A, ClC-5 channel is an apical iodide
channel. Despite Cl preference over I, ClC-5 channel supports apical efflux of I from the thyroid cytoplasm, where it reaches much higher
concentrations than in other cell types. B, ClC-5 channel supports chloride cycling necessary for the activity of pendrin, acting as an apical I/Cl
exchanger in the thyrocyte. C, ClC-5 channel indirectly regulates pendrin expression.
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iodide conductance at the apical plasma membrane (Fig. 5,
model A). The occurrence of ClC-5 at the plasma membrane
has been reported in other systems (1, 6) and is compatible
with its overlapping density distribution with that of mega-
lin. The thyrocyte cytosol contains 4 mm Cl, and I con-
centration can be much higher than in other cells. Usually
low in physiological conditions (0.05–0.1 mm), free iodide
can accumulate up to 2 mm in case of organification defect
(26). Therefore, despite preference for other anions, ClC-5
could operate as an I channel in thyrocytes. Although this
possibility does not seem consistent with the chloride im-
permeability reported for the major functional iodide chan-
nel in liposomes (43), it might account for the alternative, less
specific anionic conductance found in thyroid plasma mem-
brane vesicles (47).
As a second possibility (Fig. 5, model B), ClC-5 might be
necessary at the apical membrane of thyrocytes for recycling
chloride to the follicular lumen, to support pendrin-medi-
ated I/Cl antiport (29). At variance with the urine, Cl
concentration in the tightly closed follicular lumen is ex-
pected to be low in the absence of an apical Cl conductance.
In model B, ClC-5 may be crucial to replenish the luminal
chloride pool.
A third possibility is that ClC-5 would act indirectly, by
modulating pendrin expression in thyrocytes (Fig. 5, model
C). The mechanism for the observed decrease in pendrin
expression in ClC-5 KO thyroid glands and, conversely, the
role of ClC-5 to maintain pendrin expression in normal thy-
rocytes but not in kidneys remains speculative. So far, a
decrease in pendrin mRNA has been reported only in ded-
ifferentiated thyroid carcinomas (48–50), whereas thyroid
glands are well differentiated in ClC-5 KO mice. In kidneys,
pendrin has been identified as a Cl/HCO3
 exchanger reg-
ulated in response to chronic alterations in chloride balance.
In particular, its expression was found to be reduced in
response to metabolic acidosis, even before the decline in the
number of pendrin-positive cells (51–53), and inversely re-
lated with diet-induced changes in chloride excretion (54).
Because chloride concentration is much lower in the colloid
than in urine, pendrin regulation might be more sensitive to
any perturbation of chloride transport in thyrocytes than in
kidney cells.
In conclusion, ClC-5 is abundantly expressed in themouse
thyroid gland but is not critical for apical endocytosis, con-
trary to kidney PTC. Instead, ClC-5 modulates the rate of
apical iodide efflux, either by acting as an alternative iodide
channel or by regulating pendrin expression and/or func-
tion. Our data suggest that ClC-5 may be important for Cl
homeostasis in the thyroid gland and is indeed needed for
full operation of an apical anion transport specific to thyro-
cytes. Additional studies using transfection of polarized cells
could allow resolving the precise mechanism of this new
ClC-5 function.
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